Suppr超能文献

减少尼日利亚民众对新冠疫苗的犹豫态度并提高疫苗接种率。

Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria.

作者信息

Eguavoen Amenze, Larson Heidi J, Chinye-Nwoko Fejiro, Ojeniyi Toluwanimi

机构信息

Programs Department, Nigeria Solidarity Support Fund, Lagos, Nigeria.

Department of Infectious Disease and Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom.

出版信息

J Public Health Afr. 2023 May 4;14(5):2290. doi: 10.4081/jphia.2023.2290. eCollection 2023 Apr 30.

Abstract

By May 30, 2022, there were 526,182,662 confirmed COVID- 19 cases and 6,286,057 deaths globally; of which Nigeria had recorded 256,028 confirmed cases and 3143 deaths. By the same time, Nigeria had received a total of 93.9 million doses of the COVID-19 vaccine, enough to vaccinate 25% of the population; however, only 27.4 million people (13.3% of the population) had received at least one dose of the vaccine. This article examines available evidence on COVID-19 vaccine hesitancy in Nigeria and makes recommendations for improving its uptake. Major causes of COVID-19 vaccine hesitancy identified in Nigeria were concerns around vaccine efficacy and safety, disbelief in the existence and severity of the disease, and distrust of the government. To reduce COVID-19 vaccine hesitancy and improve vaccine coverage in Nigeria, mapping vaccine acceptance and hesitancy across geographies and demographics is needed, as well as increased stakeholder communication, and effective community engagement.

摘要

截至2022年5月30日,全球累计确诊新冠肺炎病例526,182,662例,死亡6,286,057例;其中尼日利亚累计确诊256,028例,死亡3143例。同一时期,尼日利亚共收到9390万剂新冠疫苗,足以覆盖25%的人口;然而,只有2740万人(占人口的13.3%)接种了至少一剂疫苗。本文研究了尼日利亚对新冠疫苗犹豫的现有证据,并提出了提高疫苗接种率的建议。在尼日利亚,导致对新冠疫苗犹豫的主要原因包括对疫苗效力和安全性的担忧、对疾病存在及严重性的怀疑以及对政府的不信任。为减少尼日利亚对新冠疫苗的犹豫并提高疫苗接种率,需要对不同地区和人群的疫苗接受度和犹豫情况进行摸底,加强利益相关方沟通,并开展有效的社区参与活动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0984/10365642/cb93042fc23a/jpha-14-5-2290-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验